106 related articles for article (PubMed ID: 28323962)
21. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
22. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.
Ripping TM; Hubbard RA; Otten JD; den Heeten GJ; Verbeek AL; Broeders MJ
Int J Cancer; 2016 Apr; 138(7):1619-25. PubMed ID: 26537645
[TBL] [Abstract][Full Text] [Related]
23. Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
Jap TS; Chiu CY; Won JG; Wu YC; Chen HS
Clin Endocrinol (Oxf); 2005 Mar; 62(3):336-42. PubMed ID: 15730416
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.
Cortesi L; Turchetti D; Marchi I; Fracca A; Canossi B; Rachele B; Silvia R; Rita PA; Pietro T; Massimo F
BMC Cancer; 2006 Aug; 6():210. PubMed ID: 16916448
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Besnard PE; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Peterse H; Tilanus-Linthorst MM; Muller SH; Meijer S; Oosterwijk JC; Beex LV; Tollenaar RA; de Koning HJ; Rutgers EJ; Klijn JG;
N Engl J Med; 2004 Jul; 351(5):427-37. PubMed ID: 15282350
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
Kriege M; Brekelmans CT; Obdeijn IM; Boetes C; Zonderland HM; Muller SH; Kok T; Manoliu RA; Besnard AP; Tilanus-Linthorst MM; Seynaeve C; Bartels CC; Kaas R; Meijer S; Oosterwijk JC; Hoogerbrugge N; Tollenaar RA; Rutgers EJ; de Koning HJ; Klijn JG
Breast Cancer Res Treat; 2006 Nov; 100(1):109-19. PubMed ID: 16791481
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.
Brekelmans CT; Seynaeve C; Bartels CC; Tilanus-Linthorst MM; Meijers-Heijboer EJ; Crepin CM; van Geel AA; Menke M; Verhoog LC; van den Ouweland A; Obdeijn IM; Klijn JG;
J Clin Oncol; 2001 Feb; 19(4):924-30. PubMed ID: 11181654
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
29. Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Saadatmand S; Obdeijn IM; Rutgers EJ; Oosterwijk JC; Tollenaar RA; Woldringh GH; Bergers E; Verhoef C; Heijnsdijk EA; Hooning MJ; de Koning HJ; Tilanus-Linthorst MM
Int J Cancer; 2015 Oct; 137(7):1729-38. PubMed ID: 25820931
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
[TBL] [Abstract][Full Text] [Related]
31. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
[TBL] [Abstract][Full Text] [Related]
32. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.
Tham E; Grandell U; Lindgren E; Toss G; Skogseid B; Nordenskjöld M
J Clin Endocrinol Metab; 2007 Sep; 92(9):3389-95. PubMed ID: 17623761
[TBL] [Abstract][Full Text] [Related]
33. The impact of breast cancer screening among younger women in the Barretos Region, Brazil.
De Castro Mattos JS; Mauad EC; Syrjänen K; Longatto-Filho A; Haikel RL; Da Costa Vieira RA; Silva TB; De Barros N
Anticancer Res; 2013 Jun; 33(6):2651-5. PubMed ID: 23749923
[TBL] [Abstract][Full Text] [Related]
34. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
Ellard S; Hattersley AT; Brewer CM; Vaidya B
Clin Endocrinol (Oxf); 2005 Feb; 62(2):169-75. PubMed ID: 15670192
[TBL] [Abstract][Full Text] [Related]
35. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
[TBL] [Abstract][Full Text] [Related]
37. [Summary of the practice guideline 'Diagnosis of breast cancer' (second revision) from the Dutch College of General Practitioners].
Wiersma T; de Bock GH; Corsten MC; Scheele ME; Goudswaard AN
Ned Tijdschr Geneeskd; 2009; 153():A154. PubMed ID: 19818178
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Le-Petross HT; Whitman GJ; Atchley DP; Yuan Y; Gutierrez-Barrera A; Hortobagyi GN; Litton JK; Arun BK
Cancer; 2011 Sep; 117(17):3900-7. PubMed ID: 21365619
[TBL] [Abstract][Full Text] [Related]
39. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
40. p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
Nozières C; Zhang CX; Buffet A; Dupasquier S; Vargas-Poussou R; Guillaud-Bataille M; Cordier-Bussat M; Ruszniewski P; Christin-Maitre S; Murat A; Groussin L; Vezzosi D; Cardot-Bauters C; Hervieu V; Joly MO; Giraud S; Odou MF; Gimenez-Roqueplo AP; Goudet P; Borson-Chazot F; Calender A;
Ann Endocrinol (Paris); 2014 Jul; 75(3):133-40. PubMed ID: 24997771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]